Related references
Note: Only part of the references are listed.Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors
Weilian Yang et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Bradykinin Promotes the Chemotactic Invasion of Primary Brain Tumors
Vedrana Montana et al.
JOURNAL OF NEUROSCIENCE (2011)
Noncanonical intracrine action
Richard N. Re et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Bradykinin Protects Against Brain Microvascular Endothelial Cell Death Induced by Pathophysiological Stimuli
Veronica Bovenzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R. Gilbert et al.
NEURO-ONCOLOGY (2010)
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe8ψ(CH2NH)Arg9]-BK in a F98 glioma rat model: An MRI study
Jerome Cote et al.
NEUROPEPTIDES (2010)
Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients
C. Nieder et al.
CLINICAL ONCOLOGY (2009)
Cerebral ischemia-reperfusion injury in rats-A 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation
Deepu R. Pillai et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
Rolf F. Barth et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life
Hemant Sarin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model
Kristoph Jahnke et al.
NEURO-ONCOLOGY (2009)
Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor
Simon Belanger et al.
PEPTIDES (2009)
Novel kinin B1 receptor agonists with improved pharmacological profiles
Jerome Cote et al.
PEPTIDES (2009)
Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists
Joris H. Robben et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Recent advances in blood-brain barrier disruption as a CNS delivery strategy
Marc-Andre Bellavance et al.
AAPS JOURNAL (2008)
Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer
Jessica Chee et al.
BIOLOGICAL CHEMISTRY (2008)
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B1 and B2 receptors
M. Abdouh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Ludenne Juillerat-Jeanneret
DRUG DISCOVERY TODAY (2008)
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation
Martin Savard et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Strategies to advance translational research into brain barriers
Edward Neuwelt et al.
LANCET NEUROLOGY (2008)
Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma
Jessica Chee et al.
BIOLOGICAL CHEMISTRY (2007)
Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30
Chetana M. Revankar et al.
ACS CHEMICAL BIOLOGY (2007)
Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model
David Mathieu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2007)
Molecularly targeted therapy for malignant glioma
Sith Sathornsumetee et al.
CANCER (2007)
Chemotherapy delivery issues in central nervous system malignancy: A reality check
Leslie L. Muldoon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
David Mathieu et al.
CURRENT CLINICAL PHARMACOLOGY (2007)
Novel therapies for hereditary angioedema
Bruce L. Zuraw
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
The role of chemotherapy in the treatment of malignant astrocytomas
D Mathieu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2006)
G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm
Fernand Gobeil et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2006)
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999
S Hoffman et al.
NEURO-ONCOLOGY (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread
R Maroldi et al.
EUROPEAN RADIOLOGY (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model
RC Cardoso et al.
BMC NEUROSCIENCE (2004)
Development of novel targeted therapies in the treatment of malignant glioma
JN Rich et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries
B Erdlenbruch et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems - Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature
MU Norman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
CV Borlongan et al.
BRAIN RESEARCH BULLETIN (2003)
Modulation of tumor-selective vascular blood flow and extravasation by the stable prostaglandin I-2 analogue beraprost sodium
S Tanaka et al.
JOURNAL OF DRUG TARGETING (2003)
Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase
M Uchida et al.
NEUROLOGICAL RESEARCH (2002)
Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice
B Simard et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Kinin B1 receptor antagonists with multi-enzymatic resistance properties
W Neugebauer et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy
I Hayashi et al.
LIFE SCIENCES (2002)
Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors
YH Liu et al.
NEUROLOGICAL RESEARCH (2001)
The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier - From concept to clinical evaluation
DF Emerich et al.
CLINICAL PHARMACOKINETICS (2001)
Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat
MH Sarker et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Kinin B1 receptor expression and function on human brain endothelial cells
A Prat et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Intravenous Cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in bats with metastatic tumors in the brain
DF Emerich et al.
PHARMACEUTICAL RESEARCH (2000)
Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations
A Misra et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Inflammatory mediators and modulation of blood-brain barrier permeability
NJ Abbott
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Share Paper
